{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:15:20Z","timestamp":1758636920558,"version":"3.44.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>There is little evidence supporting the use of a water-soluble contrast challenge (WSCC) for conservative management of nonadhesive small bowel obstruction (NASBO). Our objective was to evaluate the prognostic value of the WSCC in a diverse group of patients with NASBO in comparison with patients with adhesive small bowel obstruction (ASBO).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY DESIGN:<\/jats:title>\n            <jats:p>Retrospective chart review of patients with ASBO or NASBO who underwent a WSCC during a 4-year time period was performed. The primary study endpoint was any intervention for small bowel obstruction during the initial admission or within 30 days of discharge.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>A total of 106 patients were included, 53 with ASBO (mean age 64 \u00b1 13 years [SD]; 55% women) and 53 with NASBO (mean age 59 \u00b1 13 years [SD]; 57% women). A higher rate of interventions during admission or within 30 days of discharge was seen in patients with NASBO compared with ASBO (24\/53 [45%] vs 12\/53 [23%]; p = 0.01), including those with colonic transit times of less than 36 hours (14\/41 [34%] vs 5\/43 [12%]; p = 0.01). Using multivariate analysis, transit time greater than 36 hours remained an independent predictor of an intervention during admission or within 30 days of discharge (p &lt; 0.001, odds ratio 19.0), after controlling for the type of small bowel obstruction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>A majority of patients with NASBO were successfully managed conservatively during a 30-day period, supporting the use of WSCC in patients with NASBO; however, patients with NASBO had a higher rate of interventions during admission or within 30 days of discharge.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/xcs.0000000000000020","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:03:23Z","timestamp":1649120603000},"page":"121-128","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Value of Water-Soluble Contrast Challenge for Nonadhesive Small Bowel Obstruction"],"prefix":"10.1097","volume":"234","author":[{"given":"M","family":"Hunter Lanier","sequence":"first","affiliation":[{"name":"From the Mallinckrodt Institute of Radiology (Lanier, Ludwig, Mellnick), Washington University School of Medicine, St Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R","family":"Ludwig","sequence":"additional","affiliation":[{"name":"From the Mallinckrodt Institute of Radiology (Lanier, Ludwig, Mellnick), Washington University School of Medicine, St Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obeid","family":"Ilahi","sequence":"additional","affiliation":[{"name":"the Department of Surgery (Ilahi), Washington University School of Medicine, St Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Mellnick","sequence":"additional","affiliation":[{"name":"From the Mallinckrodt Institute of Radiology (Lanier, Ludwig, Mellnick), Washington University School of Medicine, St Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"R1-20250821","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.rcl.2015.06.008","article-title":"Bowel obstruction.","volume":"53","author":"Gore","year":"2015","journal-title":"Radiol Clin North Am"},{"key":"R2-20250821","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.mcna.2008.01.003","article-title":"Mechanical obstruction of the small bowel and colon.","volume":"92","author":"Cappell","year":"2008","journal-title":"Med Clin North Am"},{"key":"R3-20250821","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/acem.12150","article-title":"Adult small bowel obstruction.","volume":"20","author":"Taylor","year":"2013","journal-title":"Acad Emerg Med"},{"key":"R4-20250821","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13017-018-0185-2","article-title":"Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the World Society of Emergency Surgery ASBO Working Group.","volume":"13","author":"Ten Broek","year":"2018","journal-title":"World J Emerg Surg"},{"key":"R5-20250821","first-page":"Cd004651","article-title":"Oral water soluble contrast for the management of adhesive small bowel obstruction.","volume":"2007","author":"Abbas","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20250821","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11605-012-2011-6","article-title":"Enhancement of a small bowel obstruction model using the Gastrografin\u00ae challenge test.","volume":"17","author":"Goussous","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"R7-20250821","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jss.2018.08.019","article-title":"A significant proportion of small bowel obstructions require >48 hours to resolve after Gastrografin.","volume":"233","author":"Mulder","year":"2019","journal-title":"J Surg Res"},{"key":"R8-20250821","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.amjsurg.2015.06.012","article-title":"Water-soluble contrast agent in adhesive small bowel obstruction: a systematic review and meta-analysis of diagnostic and therapeutic value.","volume":"211","author":"Ceresoli","year":"2016","journal-title":"Am J Surg"},{"key":"R9-20250821","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s00261-018-1591-3","article-title":"Small bowel obstruction and the Gastrografin challenge.","volume":"43","author":"D\u2019Agostino","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"R10-20250821","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/TA.0000000000001499","article-title":"Multi-institutional, prospective, observational study comparing the Gastrografin challenge versus standard treatment in adhesive small bowel obstruction.","volume":"83","author":"Zielinski","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"R11-20250821","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jss.2015.11.017","article-title":"Long-term outcomes of Gastrografin in small bowel obstruction.","volume":"202","author":"Baghdadi","year":"2016","journal-title":"J Surg Res"},{"key":"R12-20250821","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.surg.2016.11.026","article-title":"Use of water-soluble contrast medium (Gastrografin) does not decrease the need for operative intervention nor the duration of hospital stay in uncomplicated acute adhesive small bowel obstruction? A multicenter, randomized, clinical trial (Adhesive Small Bowel Obstruction Study) and systematic review.","volume":"161","author":"Scott\u00e9","year":"2017","journal-title":"Surgery"},{"key":"R13-20250821","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1445-2197.2005.03491.x","article-title":"Randomized controlled trial of Gastrografin in adhesive small bowel obstruction.","volume":"75","author":"Burge","year":"2005","journal-title":"ANZ J Surg"},{"key":"R14-20250821","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/110241500750009681","article-title":"Upper gastrointestinal contrast study in the management of small bowel obstruction\u2013a prospective randomised study.","volume":"166","author":"Fevang","year":"2000","journal-title":"Eur J Surg"},{"key":"R15-20250821","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00268-008-9694-6","article-title":"Water-soluble contrast medium (Gastrografin) value in adhesive small intestine obstruction (ASIO): a prospective, randomized, controlled, clinical trial.","volume":"32","author":"Di Saverio","year":"2008","journal-title":"World J Surg"},{"key":"R16-20250821","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1503\/cjs.024009","article-title":"Impact of Gastrografin in clinical practice in the management of adhesive small bowel obstruction.","volume":"54","author":"Srinivasa","year":"2011","journal-title":"Can J Surg"},{"key":"R17-20250821","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1177\/0003134820973028","article-title":"Malignant bowel obstruction in the time of the COVID-19 pandemic.","volume":"86","author":"Fallon","year":"2020","journal-title":"Am Surg"},{"key":"R18-20250821","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/bjs.7019","article-title":"Systematic review and meta-analysis of the diagnostic and therapeutic role of water-soluble contrast agent in adhesive small bowel obstruction.","volume":"97","author":"Branco","year":"2010","journal-title":"Br J Surg"},{"key":"R19-20250821","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00423-017-1605-6","article-title":"Value of Gastrografin in adhesive small bowel obstruction.","volume":"402","author":"Weiss","year":"2017","journal-title":"Langenbecks Arch Surg"},{"key":"R20-20250821","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.amjsurg.2019.09.031","article-title":"Evaluation of a water-soluble contrast protocol for small bowel obstruction: a Southwestern Surgical Congress multicenter trial.","volume":"218","author":"Moskowitz","year":"2019","journal-title":"Am J Surg"},{"key":"R21-20250821","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s11605-017-3418-x","article-title":"Defining the need for surgery in small-bowel obstruction.","volume":"21","author":"Kuehn","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"R22-20250821","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.surg.2013.07.002","article-title":"Use of the Gastrografin challenge in patients with a history of abdominal or pelvic malignancy.","volume":"154","author":"Khasawneh","year":"2013","journal-title":"Surgery"},{"issue":"1 Suppl","key":"R23-20250821","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jpainsymman.2007.04.011","article-title":"Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction.","volume":"34","author":"Anthony","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"R24-20250821","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/0269216317726430","article-title":"A retrospective audit on usage of Diatrizoate Meglumine (Gastrografin\u00ae) for intestinal obstruction or constipation in patients with advanced neoplasms.","volume":"32","author":"Heng","year":"2018","journal-title":"Palliat Med"},{"key":"R25-20250821","first-page":"476","article-title":"Outcomes of gynecologic oncology patients undergoing Gastrografin small bowel follow-through studies.","volume":"59","author":"Walters","year":"2014","journal-title":"J Reprod Med"},{"key":"R26-20250821","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2214\/AJR.21.26132","article-title":"Water-soluble contrast challenge for suspected small bowel obstruction: technical success rate, accuracy, and clinical outcomes.","volume":"217","author":"Lawrence","year":"2021","journal-title":"AJR"},{"key":"R27-20250821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-200207000-00002","article-title":"Therapeutic value of Gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial.","volume":"236","author":"Choi","year":"2002","journal-title":"Ann Surg"},{"key":"R28-20250821","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.annonc.a058345","article-title":"Management of bowel obstruction in advanced and terminal cancer patients.","volume":"4","author":"Ripamonti","year":"1993","journal-title":"Ann Oncol"},{"key":"R29-20250821","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/SLA.0000000000002164","article-title":"Survival, healthcare utilization, and end-of-life care among older adults with malignancy-associated bowel obstruction: comparative study of surgery, venting gastrostomy, or medical management.","volume":"267","author":"Lilley","year":"2018","journal-title":"Ann Surg"}],"container-title":["Journal of the American College of Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:03:10Z","timestamp":1755806590000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/xcs.0000000000000020","relation":{},"ISSN":["1072-7515"],"issn-type":[{"type":"print","value":"1072-7515"}],"subject":[],"published":{"date-parts":[[2022,1,17]]}}}